Promise of Composite Pain Index as a single pain outcome for sickle cell disease across the lifespan.
Reema KashifTanya Wallace-FarquharsonCandice Adams-MitchellYingwei YaoRobert E MolokieDiana J WilkieA Kyle MackPublished in: Pediatric blood & cancer (2024)
The initial validation of CPI as a single pain outcome measure represents a significant advancement in pain assessment for SCD. Further validation is warranted for the CPI as a measure is for both clinicians and researchers to enable longitudinal pain assessment from age 8 years across the lifespan as children age into adult care.